Variations in the Frequency and Type of Infections in Heart Transplantation According to the Immunosuppression Regimen

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2558-2559

  Aguero J ^a   Almenar, L ^a   Martinez Dolz, L ^a   Chamorro, C ^a   Moro, J ^a   Zorio, E ^a   Arnau, M A ^a   Rueda, J ^a   Izquierdo, M ^a   Salvador, A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TSUKUBAENOLIDE;

ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; FOLLOW UP; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SURVIVAL;

DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFECTION; PATIENT SELECTION; RETROSPECTIVE STUDIES; TIME FACTORS; VIRUS DISEASES;

EID: 33750628890     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.191     Document Type: Article

References (6)

1. Johnson M.R., Mullen G.M., O'Sullivan E.J., et al. Risk/benefit ratio of perioperative OKT3 in cardiac transplantation. Am J Cardiol 74 (1994) 261
2. Hershberger R.E., Starling R.C., Eisen H.J., et al. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med 352 (2005) 2705
3. Mehra M.R., Zucker M.J., Wagoner L., et al. A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. J Heart Lung Transplant 24 (2005) 1297
4. Costanzo-Nordin M.R., O'Sullivan E.J., Johnson M.R., et al. Prospective randomised trial of OKT3 versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation. J Heart Transplant 9 (1990) 306
5. Taylor D.O., Barr M.L., Radovancevic B., et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18 (1999) 336
6. Kobashigawa J., Miller L., Renlund D., et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplantation recipients. Transplantation 66 (1998) 507